Evaluating the association of rs6983267 polymorphism of the
CCAT2
Polymorphism
Thyroid cancer
lncRNA
rs6983267
Journal
Molecular biology research communications
ISSN: 2345-2005
Titre abrégé: Mol Biol Res Commun
Pays: Iran
ID NLM: 101613459
Informations de publication
Date de publication:
2023
2023
Historique:
medline:
1
8
2023
pubmed:
1
8
2023
entrez:
1
8
2023
Statut:
ppublish
Résumé
Thyroid cancer is the most common malignancy of the endocrine system. LncRNAs play critical role in various cellular processes and are associated with several diseases. CCAT2 is a lncRNA molecule overexpressed in thyroid cancer. Single nucleotide polymorphisms in
Identifiants
pubmed: 37525664
doi: 10.22099/mbrc.2023.47622.1839
pmc: PMC10387174
doi:
Types de publication
Journal Article
Langues
eng
Pagination
127-131Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare.
Références
BMC Cancer. 2022 Feb 10;22(1):160
pubmed: 35144566
Crit Rev Clin Lab Sci. 2016;53(1):29-39
pubmed: 26398894
Int J Mol Med. 2020 Dec;46(6):2047-2056
pubmed: 33125134
Cancer Med. 2019 May;8(5):2303-2312
pubmed: 30883028
Front Genet. 2020 Feb 27;10:1406
pubmed: 32174954
Front Oncol. 2020 Jun 11;10:941
pubmed: 32596158
Cancers (Basel). 2021 Mar 18;13(6):
pubmed: 33803619
Int J Mol Sci. 2021 Nov 19;22(22):
pubmed: 34830370
BMC Genomics. 2011 Nov 30;12 Suppl 3:S9
pubmed: 22369494
Mol Cell Endocrinol. 2018 Jul 5;469:11-22
pubmed: 28751134
Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12224-12231
pubmed: 33336741
Med Sci Monit. 2016 Jun 02;22:1866-71
pubmed: 27251952
Front Genet. 2020 Jun 30;11:550
pubmed: 32714364
Semin Cancer Biol. 2022 Feb;79:180-196
pubmed: 33249201
Oncotarget. 2017 Nov 7;8(66):110635-110649
pubmed: 29299175
Int J Mol Sci. 2022 Apr 22;23(9):
pubmed: 35563021
J Hematol Oncol. 2013 May 31;6:37
pubmed: 23725405
Front Cell Neurosci. 2019 Jul 31;13:352
pubmed: 31417368
Front Genet. 2020 Nov 30;11:527484
pubmed: 33329688
Genome Res. 2018 Apr;28(4):432-447
pubmed: 29567676
Endocr Relat Cancer. 2018 Feb;25(2):R59-R82
pubmed: 29146581
Front Oncol. 2021 Apr 27;11:564296
pubmed: 33987081